OYO's parent company, Prism Hospitality, has finally crossed a milestone many investors have been waiting for.
The company has reportedly received SEBI's approval for its confidential DRHP, clearing the first major regulatory hurdle on its road to a potential ₹6,650 crore IPO.
For many investors tracking OYO in the unlisted market, the news sounds exciting.
But before anyone rushes to buy shares, there's an important question:
Does SEBI approval actually make OYO a better investment today?
The answer is more complicated than most headlines suggest.
OYO's confidential Draft Red Herring Prospectus (DRHP) has reportedly received regulatory clearance from SEBI.
This means:
The regulator has reviewed the filing.
The company can move forward with IPO preparations.
The listing process is officially underway.
However, what many investors miss is that SEBI approval is not the same as an IPO launch.
Several companies have received approvals and then waited months—or even years—before actually hitting the market.
The final decision depends on:
Market sentiment
Institutional investor appetite
Valuation expectations
Broader IPO conditions
In short:
SEBI has opened the door. OYO still has to decide when to walk through it.
Because OYO filed its DRHP confidentially, investors still do not have access to one of the most important numbers:
The final outstanding share count after conversion of all CCPS and other instruments.
And this matters a lot.
Most valuation calculations circulating in the unlisted market today assume a certain number of shares.
But if the actual post-conversion share count turns out to be higher, then:
Ownership gets diluted
Per-share valuation falls
Implied IPO value changes significantly
This means many of the prices currently being discussed in the unlisted market are based on incomplete information.
Until the public DRHP becomes available, investors are effectively trying to value a company without knowing the full denominator.
That's rarely a good idea.
One of the biggest misconceptions in the unlisted market is that buying before an IPO automatically guarantees upside.
History suggests otherwise.
The valuation that ultimately matters is the one decided by:
Institutional investors
Anchor investors
Fund managers
Public market demand
When OYO eventually launches its IPO, investors will compare it with:
Hospitality peers
Travel-tech businesses
Growth companies
Market conditions at that time
Not with today's unlisted market excitement.
If the IPO is priced close to current unlisted valuations, then the advantage of buying early largely disappears.
The assumption that "pre-IPO equals cheap" is often incorrect
Most discussions focus on potential listing gains.
Very few focus on the waiting period.
Here's what the journey could realistically look like:
Step 1: SEBI approval received today
Step 2: IPO launch may take anywhere between 3-6 months
Step 3: Listing happens
Step 4: Many pre-IPO investors remain subject to lock-in restrictions
Step 5: Actual liquidity may arrive much later
The result?
An investor buying today could potentially remain locked into the investment for 12 months or longer.
That holding period has a real cost.
Capital tied up for more than 1 year needs to generate returns that justify both the risk and the lack of liquidity.
Many investors overlook this calculation.
Instead of focusing on every movement in the unlisted share price, investors may be better served by monitoring four key developments:
This will reveal:
Actual share count
Dilution details
Shareholding structure
Financial disclosures
Market conditions will heavily influence when the company launches.
The interest shown by large investors will offer stronger valuation signals than unlisted market transactions.
This is where the market's true opinion of OYO will become visible.
OYO receiving SEBI approval is undoubtedly a positive development.
It signals progress toward a long-awaited public listing and reduces one layer of uncertainty around the IPO process.
But investors should avoid treating this as a trigger to rush into the unlisted market.
The most important pieces of information—particularly the final share count, dilution impact, and IPO valuation—are still not public.
For now, patience remains the more rational strategy.
When the public DRHP is released, investors will have access to the information required to make an informed decision rather than relying on assumptions.
In investing, missing the first headline rarely hurts.
Buying without the full picture often does.
Disclaimer: This article represents the editorial views of UnlistedZone and is intended solely for educational and informational purposes. It should not be construed as investment advice, a recommendation, or an offer to buy or sell any security. Investors should conduct their own research and consult a qualified financial advisor before making investment decisions.